Information Library
News Items - Europe
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
QUINTILES ANNOUNCES NEW EUROPEAN HEADQUARTERS
July 29, 2010 - Quintiles, announced that it is re-locating its European headquarters to within 30 minutes of Heathrow Airport at Green Park, Reading overlooking the M4 motorway.
-
QUINTILES ANNOUNCES CLINICAL RESEARCH PARTNERSHIP WITH THE UNIVERSITY MALAYA MEDICAL CENTRE
July 5, 2010 - Quintiles announces a strategic alliance agreement with the University Malaya Medical Centre (UMMC) as part of its unique Prime Site program - an initiative focused on accelerating the development of new and more effective medicines.
-
QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY
June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.
-
QUINTILES BOLSTERS MARKET ACCESS CAPABILITIES IN UK
May 20, 2010 – Quintiles today announced an agreement under which Nycomed has transferred a U.K.-based Healthcare Solutions Team to further strengthen Quintiles’ market access capabilities.
-
QUINTILES EXTENDS PHASE I CAPACITY AND CAPABILITIES
March 8, 2010 – Quintiles announced the opening of its expanded research facility in London, UK, increasing its Phase I capacity and extending its ability to drive progress in translational medicine.
-
QUINTILES AND MOVETIS ANNOUNCE STRATEGIC ALLIANCE
January 28, 2010 - Quintiles announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.
-
QUINTILES VIRTUAL CLINICAL RESEARCH COMMUNITY REACHES 2 MILLION
December 22, 2009 – Quintiles announced it has developed a community of more than 2 million clinically profiled patients who have opted in to volunteer or provide insights and guidance to advance clinical research through its proprietary Web site iGuard.org.
-
QUINTILES HONORED AS CRO OF THE YEAR AT 2009 SCRIP AWARD
Research Triangle Park, NC, December 14, 2009 – Quintiles has been named CRO of the Year by the prestigious SCRIP Awards. The panel of judges highlighted Quintiles’ breadth of services and its outstanding relationships with clients.
-
QUINTILES PARTNERS WITH FOUNDATION TRUST & UNIVERSITY TO IMPROVE PATIENT CARE AND DRIVE EFFICIENCY IN CLINICAL RESEARCH
October 26, 2009 - A significant step in driving innovation, improving patient care and increasing efficiency in early stage clinical research was taken today with the announcement that two of the UK’s leading institutions - Guy’s and St Thomas’ NHS Foundation Trust and King’s College London - have signed a collaborative agreement with Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide.
Page 1 of 1 (9 results)
